Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
Abstract INTRODUCTION Remlifanserin, or ACP‐204, is a potent serotonin 2A receptor inverse agonist under investigation for treatment of Alzheimer's disease psychosis and Lewy body dementia psychosis. A population pharmacokinetics (popPK) model for remlifanserin was developed to evaluate the impact o...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wiley
2026-04-01
|
| Rangatū: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1002/trc2.70254 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|